PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Ferric Carboxymaltose→

Ferric Carboxymaltose PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
9007-72-1
Molecular formula
Not available
Molecular weight
~150000 g/mol
Drug class
Intravenous iron(III)-carbohydrate complexparenteral iron replacement agent
Mechanism of action
A stable colloidal iron(III)-hydroxide complex with carboxymaltose carbohydrate. Following intravenous administration, iron is taken up by reticuloendothelial cells and made available for transferrin binding and incorporation into haemoglobin and iron stores; it is not a simple dissociating iron salt.
Indications / reported uses
  • Treatment of iron-deficiency anaemia in adults and eligible paediatric patients when oral iron is ineffective, not tolerated or rapid iron replacement is needed
  • Treatment of iron deficiency in selected patients with heart failure where the specific formulation is authorised; use and dosing are product-label specific

Sources: US DailyMed — INJECTAFER (ferric carboxymaltose) · EMA EPAR — Ferinject · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Ferric Carboxymaltose PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ferric Carboxymaltose Permitted Daily Exposure (PDE) report (the Ferric Carboxymaltose PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ferric Carboxymaltose Occupational Exposure Limit (OEL) report (the Ferric Carboxymaltose OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.